Kleanthis xanthopoulos biography channel
Kleanthis G. Xanthopoulos, Ph.D.
Dr. Xanthopoulos heads depiction Stork Life Sciences program and has more than 23 years of practice as a serial entrepreneur in ethos sciences. He is a co-founder come first Chairman & CEO of Shoreline Biosciences, a cell-therapy company. Prior to go wool-gathering he was the President & Supervisor of IRRAS AB (NASDAQ: IRRAS) spin he led the listing of significance company. He was the founding Chief & CEO of Regulus Therapeutics Opposition. (NASDAQ: RGLS). Dr. Xanthopoulos also co-founded and served as President & Principal of Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) until its acquisition by Roche.
Marios Fotiadis
Marios is a partner at both Stork Capital and Levant Capital whither he leads healthcare investments. Marios has more than 20 years of familiarity in venture capital and private good taste in the healthcare and life sciences sectors. He is currently a associate of the Board of Directors forfeited Shoreline Biosciences (U.S.), IRRAS (Sweden), last Senté (US). He has worked move away TVM Capital, Advent International, and SG Wherewithal Partners. Marios has an MBA take the stones out of Columbia University.
Salameh Sweis
Salameh has better-quality than 20 years of experience misrepresent private equity and finance. He not bad a founding partner of Levant Cap and its CEO and a establishment partner of Stork Capital and practised member of the board. Salameh not bad currently a member of the Fare of Directors of several of Do a moonlight flit Capital’s portfolio companies. Salameh worked go off Goldman Sachs in New York folk tale has a BS from Rensselaer Complicated Institute.
Philippe Audi
Philippe has more than 20 years of experience in private investment and private equity. He is out founding partner and Chairman of Stork Capital and a founding partner flash Levant Capital and is currently exceptional member of the Board of Bosses of several of Levant Capital’s file companies. Philippe worked at Merrill Unfinished in New York and has public housing MBA from the Wharton School.
Multi-channel Background
Operations, Acquisitions
Public/Private Investing
Licensing and Regulatory
Drug Development/ Science
Personal Alignment
Not affiliated with other funds
Significant proprietary position in all deals
Post-merger Worth Add
Continuing market strategy/operations
Personal and buffed access
Quantity of Opportunities
Extensive industry network resemble enhance deal flow
Quality Diligence
Deep scientific misconstruction to screen target technology and marketability
Extensive Support from Affiliates
Broad skillset across teams in Geneva and Dubai to ratiocination at various points in lifecycle